273 related articles for article (PubMed ID: 37607935)
1. Cancer-associated fibroblasts: tumor defenders in radiation therapy.
Zhang Y; Lv N; Li M; Liu M; Wu C
Cell Death Dis; 2023 Aug; 14(8):541. PubMed ID: 37607935
[TBL] [Abstract][Full Text] [Related]
2. Immunobiology of cancer-associated fibroblasts in the context of radiotherapy.
Hellevik T; Berzaghi R; Lode K; Islam A; Martinez-Zubiaurre I
J Transl Med; 2021 Oct; 19(1):437. PubMed ID: 34663337
[TBL] [Abstract][Full Text] [Related]
3. Cancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?
Martinez-Zubiaurre I; Hellevik T
Cell Commun Signal; 2023 May; 21(1):108. PubMed ID: 37170098
[TBL] [Abstract][Full Text] [Related]
4. Ionizing Radiation Curtails Immunosuppressive Effects From Cancer-Associated Fibroblasts on Dendritic Cells.
Berzaghi R; Tornaas S; Lode K; Hellevik T; Martinez-Zubiaurre I
Front Immunol; 2021; 12():662594. PubMed ID: 34177901
[TBL] [Abstract][Full Text] [Related]
5. Cancer-associated fibroblasts: An emerging target against esophageal squamous cell carcinoma.
Qiu L; Yue J; Ding L; Yin Z; Zhang K; Zhang H
Cancer Lett; 2022 Oct; 546():215860. PubMed ID: 35948121
[TBL] [Abstract][Full Text] [Related]
6. Interaction between Fibroblasts and Immune Cells Following DNA Damage Induced by Ionizing Radiation.
Ragunathan K; Upfold NLE; Oksenych V
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33207781
[TBL] [Abstract][Full Text] [Related]
7. The interplay between cancer associated fibroblasts and immune cells in the context of radiation therapy.
Piper M; Mueller AC; Karam SD
Mol Carcinog; 2020 Jul; 59(7):754-765. PubMed ID: 32363633
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
[TBL] [Abstract][Full Text] [Related]
9. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
[TBL] [Abstract][Full Text] [Related]
10. Fibroblasts Fuel Immune Escape in the Tumor Microenvironment.
De Jaeghere EA; Denys HG; De Wever O
Trends Cancer; 2019 Nov; 5(11):704-723. PubMed ID: 31735289
[TBL] [Abstract][Full Text] [Related]
11. Cancer-Associated Fibroblast Heterogeneity: A Factor That Cannot Be Ignored in Immune Microenvironment Remodeling.
Chen PY; Wei WF; Wu HZ; Fan LS; Wang W
Front Immunol; 2021; 12():671595. PubMed ID: 34305902
[TBL] [Abstract][Full Text] [Related]
12. Cancer associated fibroblasts tailored tumor microenvironment of therapy resistance in gastrointestinal cancers.
Sun Y; Wang R; Qiao M; Xu Y; Guan W; Wang L
J Cell Physiol; 2018 Sep; 233(9):6359-6369. PubMed ID: 29334123
[TBL] [Abstract][Full Text] [Related]
13. Emerging Role of Cancer-Associated Fibroblasts in Progression and Treatment of Hepatocellular Carcinoma.
Akkız H
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835352
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous cancer-associated fibroblasts: A new perspective for understanding immunosuppression in pancreatic cancer.
Zhang Z; Zhang H; Shi L; Wang D; Tang D
Immunology; 2022 Sep; 167(1):1-14. PubMed ID: 35569095
[TBL] [Abstract][Full Text] [Related]
15. The promising role of noncoding RNAs in cancer-associated fibroblasts: an overview of current status and future perspectives.
Fang Z; Xu J; Zhang B; Wang W; Liu J; Liang C; Hua J; Meng Q; Yu X; Shi S
J Hematol Oncol; 2020 Nov; 13(1):154. PubMed ID: 33213510
[TBL] [Abstract][Full Text] [Related]
16. Irradiated Tumor Fibroblasts Avoid Immune Recognition and Retain Immunosuppressive Functions Over Natural Killer Cells.
Yang N; Lode K; Berzaghi R; Islam A; Martinez-Zubiaurre I; Hellevik T
Front Immunol; 2020; 11():602530. PubMed ID: 33584669
[TBL] [Abstract][Full Text] [Related]
17. Targeting CAFs to overcome anticancer therapeutic resistance.
Saw PE; Chen J; Song E
Trends Cancer; 2022 Jul; 8(7):527-555. PubMed ID: 35331673
[TBL] [Abstract][Full Text] [Related]
18. Cancer-associated fibroblasts in non-small cell lung cancer: Recent advances and future perspectives.
Zhang H; Jiang H; Zhu L; Li J; Ma S
Cancer Lett; 2021 Aug; 514():38-47. PubMed ID: 34019960
[TBL] [Abstract][Full Text] [Related]
19. Metabolic Reprogramming of Cancer Associated Fibroblasts: The Slavery of Stromal Fibroblasts.
Avagliano A; Granato G; Ruocco MR; Romano V; Belviso I; Carfora A; Montagnani S; Arcucci A
Biomed Res Int; 2018; 2018():6075403. PubMed ID: 29967776
[TBL] [Abstract][Full Text] [Related]
20. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
Eskandari-Malayeri F; Rezaei M
Front Immunol; 2022; 13():996145. PubMed ID: 36275750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
